Journal article
Applications of machine learning in microbial natural product drug discovery
Abstract
INTRODUCTION: Natural products (NPs) are a desirable source of new therapeutics due to their structural diversity and evolutionarily optimized bioactivities. NPs and their derivatives account for roughly 70% of approved pharmaceuticals. However, the rate at which novel NPs are discovered has decreased. To accelerate the microbial NP discovery process, machine learning (ML) is being applied to numerous areas of NP discovery and development.
Authors
Arnold A; Alexander J; Liu G; Stokes JM
Journal
Expert Opinion on Drug Discovery, Vol. 18, No. 11, pp. 1259–1272
Publisher
Taylor & Francis
Publication Date
November 2, 2023
DOI
10.1080/17460441.2023.2251400
ISSN
1746-0441